Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Biohaven Ltd has a consensus price target of $61.16 based on the ratings of 17 analysts. The high is $148.5 issued by Wedbush on August 8, 2022. The low is $21 issued by RBC Capital on May 19, 2025. The 3 most-recent analyst ratings were released by RBC Capital, RBC Capital, and Baird on May 19, 2025, May 13, 2025, and April 28, 2025, respectively. With an average price target of $44 between RBC Capital, RBC Capital, and Baird, there's an implied 178.17% upside for Biohaven Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/19/2025 | Buy Now | 32.76% | RBC Capital | Leonid Timashev37% | $54 → $21 | Downgrade | Outperform → Sector Perform | Get Alert |
05/13/2025 | Buy Now | 241.39% | RBC Capital | Leonid Timashev37% | $61 → $54 | Maintains | Outperform | Get Alert |
04/28/2025 | Buy Now | 260.35% | Baird | Brian Skorney57% | $60 → $57 | Maintains | Outperform | Get Alert |
03/07/2025 | Buy Now | 298.29% | Morgan Stanley | Terence Flynn64% | $69 → $63 | Maintains | Overweight | Get Alert |
03/05/2025 | Buy Now | 329.9% | JP Morgan | Tessa Romero56% | $72 → $68 | Maintains | Overweight | Get Alert |
03/04/2025 | Buy Now | 241.39% | HC Wainwright & Co. | Douglas Tsao50% | $54 → $54 | Reiterates | Buy → Buy | Get Alert |
03/04/2025 | Buy Now | 285.64% | RBC Capital | Leonid Timashev37% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
02/11/2025 | Buy Now | 310.93% | Deutsche Bank | David Hoang39% | → $65 | Initiates | → Buy | Get Alert |
12/17/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | Overweight → Overweight | Get Alert |
12/17/2024 | Buy Now | 273% | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
12/04/2024 | Buy Now | 285.64% | RBC Capital | Leonid Timashev37% | $58 → $61 | Reiterates | Outperform → Outperform | Get Alert |
11/26/2024 | Buy Now | 273% | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
11/25/2024 | Buy Now | 266.68% | RBC Capital | Leonid Timashev37% | $66 → $58 | Maintains | Outperform | Get Alert |
11/14/2024 | Buy Now | 273% | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
11/13/2024 | Buy Now | 374.15% | TD Cowen | Tyler Van Buren45% | $55 → $75 | Maintains | Buy | Get Alert |
11/13/2024 | Buy Now | 317.25% | RBC Capital | Leonid Timashev37% | $68 → $66 | Maintains | Outperform | Get Alert |
10/23/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
10/04/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
10/03/2024 | Buy Now | 329.9% | JP Morgan | Tessa Romero56% | $55 → $68 | Maintains | Overweight | Get Alert |
09/24/2024 | Buy Now | 317.25% | Bernstein | William Pickering38% | $55 → $66 | Maintains | Outperform | Get Alert |
09/24/2024 | Buy Now | 291.96% | B of A Securities | Jason Gerberry59% | $52 → $62 | Maintains | Buy | Get Alert |
09/24/2024 | Buy Now | 329.9% | RBC Capital | Leonid Timashev37% | $59 → $68 | Maintains | Outperform | Get Alert |
09/24/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
09/24/2024 | Buy Now | 273% | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
09/23/2024 | Buy Now | 279.32% | Leerink Partners | Marc Goodman72% | $55 → $60 | Maintains | Outperform | Get Alert |
09/23/2024 | Buy Now | 380.47% | Piper Sandler | Christopher Raymond54% | $66 → $76 | Maintains | Overweight | Get Alert |
09/23/2024 | Buy Now | 279.32% | Baird | Brian Skorney57% | $58 → $60 | Maintains | Outperform | Get Alert |
09/16/2024 | Buy Now | 260.35% | Jefferies | Amy Li2% | → $57 | Initiates | → Buy | Get Alert |
09/04/2024 | Buy Now | 247.71% | Bernstein | William Pickering38% | → $55 | Initiates | → Outperform | Get Alert |
09/04/2024 | Buy Now | 273% | RBC Capital | Leonid Timashev37% | $59 → $59 | Reiterates | Outperform → Outperform | Get Alert |
08/19/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
08/13/2024 | Buy Now | 241.39% | UBS | Ashwani Verma46% | $55 → $54 | Maintains | Buy | Get Alert |
08/12/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
07/24/2024 | Buy Now | 266.68% | Morgan Stanley | Terence Flynn64% | → $58 | Initiates | → Overweight | Get Alert |
06/18/2024 | Buy Now | 273% | RBC Capital | Leonid Timashev37% | $59 → $59 | Reiterates | Outperform → Outperform | Get Alert |
05/30/2024 | Buy Now | 273% | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
05/30/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
05/13/2024 | Buy Now | 273% | HC Wainwright & Co. | Douglas Tsao50% | $63 → $59 | Maintains | Buy | Get Alert |
04/23/2024 | Buy Now | 279.32% | UBS | Ashwani Verma46% | $59 → $60 | Maintains | Buy | Get Alert |
04/18/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
04/10/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
04/09/2024 | Buy Now | 285.64% | RBC Capital | Leonid Timashev37% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
03/04/2024 | Buy Now | 298.29% | HC Wainwright & Co. | Douglas Tsao50% | $50 → $63 | Maintains | Buy | Get Alert |
03/01/2024 | Buy Now | 285.64% | RBC Capital | Leonid Timashev37% | $62 → $61 | Maintains | Outperform | Get Alert |
03/01/2024 | Buy Now | 247.71% | TD Cowen | Tyler Van Buren45% | $35 → $55 | Maintains | Outperform | Get Alert |
02/23/2024 | Buy Now | 254.03% | JP Morgan | Tessa Romero56% | $32 → $56 | Maintains | Overweight | Get Alert |
02/16/2024 | Buy Now | 291.96% | RBC Capital | Leonid Timashev37% | → $62 | Initiates | → Outperform | Get Alert |
02/06/2024 | Buy Now | 273% | UBS | Ashwani Verma46% | → $59 | Initiates | → Buy | Get Alert |
12/22/2023 | Buy Now | 216.1% | HC Wainwright & Co. | Douglas Tsao50% | → $50 | Initiates | → Buy | Get Alert |
12/08/2023 | Buy Now | 266.68% | Baird | Brian Skorney57% | → $58 | Initiates | → Outperform | Get Alert |
11/20/2023 | Buy Now | 102.3% | JP Morgan | Tessa Romero56% | $26 → $32 | Maintains | Overweight | Get Alert |
11/15/2023 | Buy Now | 127.59% | Piper Sandler | Christopher Raymond54% | $29 → $36 | Maintains | Overweight | Get Alert |
08/16/2023 | Buy Now | 51.73% | JP Morgan | Tessa Romero56% | $27 → $24 | Maintains | Overweight | Get Alert |
07/17/2023 | Buy Now | 95.98% | Cantor Fitzgerald | Charles Duncan68% | → $31 | Reiterates | Overweight → Overweight | Get Alert |
06/06/2023 | Buy Now | 77.02% | BTIG | Thomas Shrader39% | $24 → $28 | Reiterates | → Buy | Get Alert |
04/04/2023 | Buy Now | 95.98% | Cantor Fitzgerald | Charles Duncan68% | $27 → $31 | Maintains | Overweight | Get Alert |
01/24/2023 | Buy Now | 51.73% | SVB Leerink | Marc Goodman72% | → $24 | Initiates | → Outperform | Get Alert |
01/04/2023 | Buy Now | 45.41% | JP Morgan | Tessa Romero56% | → $23 | Initiates | → Overweight | Get Alert |
12/02/2022 | Buy Now | 51.73% | BTIG | Thomas Shrader39% | → $24 | Initiates | → Buy | Get Alert |
10/26/2022 | Buy Now | 32.76% | Piper Sandler | Christopher Raymond54% | $23 → $21 | Maintains | Overweight | Get Alert |
10/12/2022 | Buy Now | 45.41% | Piper Sandler | Christopher Raymond54% | → $23 | Initiates | → Overweight | Get Alert |
08/19/2022 | Buy Now | — | Piper Sandler | Christopher Raymond54% | — | Downgrade | Overweight → Neutral | Get Alert |
08/08/2022 | Buy Now | 838.82% | Wedbush | Laura Chico46% | → $148.5 | Downgrade | Outperform → Neutral | Get Alert |
The latest price target for Biohaven (NYSE:BHVN) was reported by RBC Capital on May 19, 2025. The analyst firm set a price target for $21.00 expecting BHVN to rise to within 12 months (a possible 32.76% upside). 37 analyst firms have reported ratings in the last year.
The latest analyst rating for Biohaven (NYSE:BHVN) was provided by RBC Capital, and Biohaven downgraded their sector perform rating.
There is no last upgrade for Biohaven
The last downgrade for Biohaven Ltd happened on May 19, 2025 when RBC Capital changed their price target from $54 to $21 for Biohaven Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biohaven, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biohaven was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.
While ratings are subjective and will change, the latest Biohaven (BHVN) rating was a downgraded with a price target of $54.00 to $21.00. The current price Biohaven (BHVN) is trading at is $15.82, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.